Mark E. Robson - Concepedia

Author

Mark E. Robson

Memorial Sloan Kettering Cancer Center ORCID

Also Known As

Alvaro N. A. Monteiro, Barbara Wappenschmidt, Caldes, Trinidad, Catriona Maclean, Csilla I Szabo, Durda, Katarzyna, Francesca Damiola, Gianluca Severi, J. F. Rivero-Rodriguez, J.F. Rivero-Rodriguez

949

Publications

57.7K

Citations

114

H-Index

262

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center Cornell University University of Pennsylvania Dana-Farber Cancer Institute University of Toronto

About

Mark E. Robson is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	17	20	7.6K
2	Engineering	9	9	315
3	Education	3	3	49
4	Business	1	1	14
5	Management	1	1	16

Mark E. Robson

316

Publications

48.1K

Citations

H-Index

Page 1

	Year	Citations
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients Ahmet Zehir, Ryma Benayed, Ronak Shah, Nature Medicine Metastatic CancerOncologySomatic VariantMutational LandscapeTumor Heterogeneity	2017	3.4K
Olaparib for Metastatic Breast Cancer in Patients with a Germline <i>BRCA</i> Mutation Mark E. Robson, Seock‐Ah Im, Elżbieta Senkus, New England Journal of Medicine	2017	3.1K
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial Andrew Tutt, Mark E. Robson, Judy E. Garber, The Lancet Breast OncologyOncologyPathologyPolymerase Inhibitor OlaparibBreast Cancer	2010	1.6K
Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer Colin C. Pritchard, Joaquı́n Mateo, Michael F. Walsh, New England Journal of Medicine	2016	1.6K
ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer Alessandra Gennari, Fabrice André, Carlos H. Barrios, Annals of Oncology Surgical OncologyMetastatic Breast CancerBreast OncologyMedicineCancer Management	2021	1.3K
Risk-Reducing Salpingo-oophorectomy in Women with a<i>BRCA1</i>or<i>BRCA2</i>Mutation Noah D. Kauff, Jaya M. Satagopan, Mark E. Robson, New England Journal of Medicine	2002	1.2K
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes Nasim Mavaddat, Kyriaki Michailidou, Joe Dennis, The American Journal of Human Genetics	2018	1.1K
The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers Pedram Razavi, Matthew T. Chang, Guotai Xu, Cancer Cell Breast OncologyGenomic LandscapeCancer GenomicsBreast CancerRadiation Oncology	2018	956
American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility Mark E. Robson, Angela R. Bradbury, Banu Arun, Journal of Clinical Oncology Genetic TestingCancer PathologyGeneticsGenetic EpidemiologyPathology	2015	934
Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk Douglas F. Easton, Paul D.P. Pharoah, Antonis C. Antoniou, New England Journal of Medicine	2015	919

Page 1